Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
Cash Earnings per Share (CEPS)

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   CEPS(Rs) 36.4630.5119.4217.17

What is the latest Cash Earnings per Share (CEPS) ratio of CORONA REMEDIES ?

The latest Cash Earnings per Share (CEPS) ratio of CORONA REMEDIES is 36.46 based on Mar2026 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202636.46
Mar202530.51
Mar202419.42
Mar202317.17

How is Cash Earnings per Share (CEPS) of CORONA REMEDIES Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2026 36.46
19.50
Mar2025 30.51
57.11
Mar2024 19.42
13.10
Mar2023 17.17 -

Other Financial Ratios of CORONA REMEDIES


Compare Cash Earnings per Share (CEPS) ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,240.3 Cr -1.7% 2.3% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹447,716.0 Cr 0.1% -0.6% 15.2% Stock Analytics
DIVIS LABORATORIES ₹248,120.0 Cr -0.6% 8.7% 53% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,038.0 Cr -0.8% -1.7% 34.7% Stock Analytics
CIPLA ₹110,858.0 Cr -0.6% -4.2% -12.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,828.7 Cr 2.7% -0.7% -12.1% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-1.7%

2.3%

NA
SENSEX

-0.6%

-4.4%

-8.7%


You may also like the below Video Courses